Short answer
IRONWOOD PHARMACEUTICALS INC (IRWD) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2025 earnings press release referenced via exhibit: full financial results contained in the attached exhibit, not in filing body.
IRONWOOD PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2025 earnings press release referenced via exhibit: full financial results contained in the attached exhibit, not in filing body
- Investors should review Exhibit for key metrics: revenue, EPS, and guidance updates for IRWD's GI-focused portfolio
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other IRONWOOD PHARMACEUTICALS INC 8-K filings
Get the next IRWD 8-K as it lands
Follow IRWD for push alerts, or ask the research agent what this filing means.